Trial intelligence / Profile preview

SONAS Ultrasound Device for the Detection of Ischemic and Hemorrhagic Stroke

NCT03296852Phase 1Completed

Sponsor
University of California, Los Angeles
Start
Apr 2018
Primary completion
Sep 2018
Countries
1
01

Overview

Phase 1, open-label, single-arm trial, sponsored by University of California, Los Angeles. Primary endpoint: Blood brain barrier impairment by extravasation of Gadolinium into the brain tissue at 5 hours. Started Apr 2018; status: completed.

Beyond the preview

Go deeper on NCT03296852.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03296852.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call